Stock analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research report issued on Wednesday. The firm set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
Shares of CALA stock opened at $0.00 on Wednesday. Calithera Biosciences has a 12-month low of $0.00 and a 12-month high of $0.12. The business’s fifty day simple moving average is $0.01 and its 200-day simple moving average is $0.02.
Calithera Biosciences Company Profile
Further Reading
- Five stocks we like better than Calithera Biosciences
- How to Use High Beta Stocks to Maximize Your Investing Profits
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- NYSE Stocks Give Investors a Variety of Quality Options
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- Market Cap Calculator: How to Calculate Market Cap
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
